Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre van Damme

Showing results (31-40 of 365) with videos related to

Pageof 37
Sort By:
World Journal of Hepatology|September 2, 2015
Three decades of hepatitis B control with vaccinationLiliane C Meireles, Rui Tato Marinho, Pierre Van Damme
The Journal of Infectious Diseases|September 30, 2021
Hepatitis B VaccinesJade Pattyn, Greet Hendrickx, Alex Vorsters, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 4, 2011
The worldwide impact of vaccination on the control and protection of viral hepatitis BLuisa Romano', Sara Paladini, Pierre Van Damme, et al.
Journal of Medical Virology|December 26, 2003
Hepatitis A vaccine: indirect evidence of immune memory 12 years after the primary courseKoen Van Herck, Pierre Van Damme, Marc Lievens, et al.
Travel Medicine and Infectious Disease|May 16, 2019
Low adherence with national travel medicine recommendations in Belgian expatriate children: A retrospective analysisIne Ilona Decuyper, Pierre Van Damme, Patrick Soentjens, et al.
Human Vaccines & Immunotherapeutics|April 12, 2021
The influenza vaccine for nursing and care professionals at emergency services in FlandersMatthijs Samyn, Guido Van Hal, Herman Vandevijvere, et al.
Pharmacoeconomics|December 18, 2002
Economic evaluations of varicella vaccination programmes: a review of the literatureNancy Thiry, Philippe Beutels, Pierre Van Damme, et al.
Expert Review of Vaccines|January 9, 2004
Methodological issues and new developments in the economic evaluation of vaccinesPhilippe Beutels, Eddy Van Doorslaer, Pierre Van Damme, et al.
BMC Public Health|June 16, 2011
Dynamics of HPV vaccination initiation in Flanders (Belgium) 2007-2009: a Cox regression modelEva Lefevere, Niel Hens, Frank De Smet, et al.
Human Vaccines & Immunotherapeutics|February 29, 2012
What counts in cytometric analysis to document vaccine immunogenicity?Benson Ogunjimi, Viggo Van Tendeloo, Pierre Van Damme, et al.
Pageof 37

Showing results (31-40 of 365) with videos related to

Sort By:
Pageof 37
World Journal of Hepatology|September 2, 2015
Three decades of hepatitis B control with vaccinationLiliane C Meireles, Rui Tato Marinho, Pierre Van Damme
The Journal of Infectious Diseases|September 30, 2021
Hepatitis B VaccinesJade Pattyn, Greet Hendrickx, Alex Vorsters, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 4, 2011
The worldwide impact of vaccination on the control and protection of viral hepatitis BLuisa Romano', Sara Paladini, Pierre Van Damme, et al.
Journal of Medical Virology|December 26, 2003
Hepatitis A vaccine: indirect evidence of immune memory 12 years after the primary courseKoen Van Herck, Pierre Van Damme, Marc Lievens, et al.
Travel Medicine and Infectious Disease|May 16, 2019
Low adherence with national travel medicine recommendations in Belgian expatriate children: A retrospective analysisIne Ilona Decuyper, Pierre Van Damme, Patrick Soentjens, et al.
Human Vaccines & Immunotherapeutics|April 12, 2021
The influenza vaccine for nursing and care professionals at emergency services in FlandersMatthijs Samyn, Guido Van Hal, Herman Vandevijvere, et al.
Pharmacoeconomics|December 18, 2002
Economic evaluations of varicella vaccination programmes: a review of the literatureNancy Thiry, Philippe Beutels, Pierre Van Damme, et al.
Expert Review of Vaccines|January 9, 2004
Methodological issues and new developments in the economic evaluation of vaccinesPhilippe Beutels, Eddy Van Doorslaer, Pierre Van Damme, et al.
BMC Public Health|June 16, 2011
Dynamics of HPV vaccination initiation in Flanders (Belgium) 2007-2009: a Cox regression modelEva Lefevere, Niel Hens, Frank De Smet, et al.
Human Vaccines & Immunotherapeutics|February 29, 2012
What counts in cytometric analysis to document vaccine immunogenicity?Benson Ogunjimi, Viggo Van Tendeloo, Pierre Van Damme, et al.
Pageof 37